Evidence map›Paper›PMID 37603075›Full record

ArticleJournal of neurology2023

Analysis of muscle magnetic resonance imaging of a large cohort of patient with VCP-mediated disease reveals characteristic features useful for diagnosis.

Diana Esteller, Marianela Schiava, José Verdú-Díaz, Rocío-Nur Villar-Quiles, Boris Dibowski, Nadia Venturelli, Pascal Laforet, Jorge Alonso-Pérez, Montse Olive, Cristina Domínguez-González and 56 more

Erratum issuedOpen access · hybridAbstract read
In one paragraph

Article in Journal of neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

66 authors at 20 institutions in 18 countries.

Diana EstellerNeurology Department, Hospital Clinic de Barcelona, Universitat de Barcelona, Barcelona, Spain.
Marianela SchiavaJohn Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute and Newcastle Hospitals NHS Foundation Trust, Center for Life, Central Parkway, Newcastle Upon Tyne, NE13BZ, United Kingdom.
José Verdú-DíazJohn Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute and Newcastle Hospitals NHS Foundation Trust, Center for Life, Central Parkway, Newcastle Upon Tyne, NE13BZ, United Kingdom.
Rocío-Nur Villar-QuilesAPHP, Centre de Référence des Maladies Neuromusculaires, Institut de Myologie, Centre de Recherche en Myologie, Sorbonne Université, APHP, Hôpital Pitié-Salpêtrière, Paris, France.
Boris DibowskiDepartment of Radiology, Assistance Publique-Hôpitaux de Paris (AP-HP), DMU Start Imaging, Raymond Poincaré Teaching Hospital, Garches, France.
Nadia VenturelliDepartment of Radiology, Assistance Publique-Hôpitaux de Paris (AP-HP), DMU Start Imaging, Raymond Poincaré Teaching Hospital, Garches, France.
Pascal LaforetDépartement de Neurologie Hôpital Raymond-Poincaré Garches France Inserm U1179, Garches, France.
Jorge Alonso-PérezServicio de Neurología. Hospital Virgen de la Candelaria, Tenerife, Spain.
Montse OliveNeuromuscular Diseases Unit, Neurology Department, Institut d'Investigació Biomèdica Sant Pau (IIB SANT PAU), Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Cristina Domínguez-GonzálezCenter for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Carmen ParadasUnidad de Enfermedades Neuromusculares, Servicio de Neurología, Hospital Virgen del Rocio, Seville, Spain.
Beatriz VélezUnidad de Enfermedades Neuromusculares, Servicio de Neurología, Hospital Virgen del Rocio, Seville, Spain.
Anna Kostera-PruszczykDepartment of Neurology, Medical University of Warsaw, ERN EURO NMD, Warsaw, Poland.
Biruta KierdaszukDepartment of Neurology, Medical University of Warsaw, ERN EURO NMD, Warsaw, Poland.
Carmelo RodolicoUOC di Neurologia e Malattie Neuromuscolari, AOU Policlinico "G. Martino", Rome, Italy.
Kristl ClaeysNeurologie, Neuromusculair Referentiecentrum, Universitaire Ziekenhuizen, Leuven, Belgium.
Endre PálNeurology Department, University of Pécs, Pécs, Hungary.
Edoardo MalfattiUniversité Paris Est, U955 INSERM, Centre de Référence de Pathologie Neuromusculaire Nord-Est-Ile-de-France, Henri Mondor Hospital, EURO-NMD, 94010, Creteil, France.
Sarah SouvannanorathUniversité Paris Est, U955 INSERM, Centre de Référence de Pathologie Neuromusculaire Nord-Est-Ile-de-France, Henri Mondor Hospital, EURO-NMD, 94010, Creteil, France.
Alicia Alonso-JiménezNeurology Department, Universitary Hospital Antwerpen, Edegem, Belgium.
Willem de RidderNeurology Department, Universitary Hospital Antwerpen, Edegem, Belgium.
Eline De SmetNeurology Department, Universitary Hospital Antwerpen, Edegem, Belgium.
George PapadimasDepartment of Neurology, Eginition Hospital, Medical School, NKUA, ERN, EURO NMD, Athens, Greece.
Constantinos PapadopoulosDepartment of Neurology, Eginition Hospital, Medical School, NKUA, ERN, EURO NMD, Athens, Greece.
Sofia XirouDepartment of Neurology, Eginition Hospital, Medical School, NKUA, ERN, EURO NMD, Athens, Greece.
Sushan LuoNeurology Department, Huashan Hospital, Fudan University, Shangai, China.
Nuria MuelasCenter for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Juan J VilchezCenter for Biomedical Network Research on Rare Diseases (CIBERER), Instituto de Salud Carlos III, Madrid, Spain.
Alba Ramos-FransiUnitat de Malalties Neuromusculars, Servei de Neurologia, Hospital Germans Tries I Pujol, Badalona, Spain.
Mauro MonforteUOC di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Giorgio TascaJohn Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute and Newcastle Hospitals NHS Foundation Trust, Center for Life, Central Parkway, Newcastle Upon Tyne, NE13BZ, United Kingdom.
Bjarne UddTampere Neuromuscular Center, Tampere University Hospital, Tampere, Finland.
Johanna PalmioTampere Neuromuscular Center, Tampere University Hospital, Tampere, Finland.
Srtuhi SriSree Chitra Tirunal Insitute for Medical Sciences and Technology, Thiruvananthapuram, India.
Sabine KrauseDepartment of Neurology, Friedrich-Baur-Institute, LMU Clinics, Munich, Germany.
Benedikt SchoserDepartment of Neurology, Friedrich-Baur-Institute, LMU Clinics, Munich, Germany.
Roberto Fernández-TorrónCentro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Adolfo López de MunainCentro de Investigación Biomédica en Red en Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain.
Elena PegoraroDepartment of Neurosciences, University of Padova, Padua, Italy.
Maria Elena FarrugiaDepartment of Neurology, Institute of Neurological Sciences, Queen Elizabeth University Hospital, Glasgow, Scotland, UK.
Mathias VorgerdHeimer Institut for Muscle Research, Klinikum Bergmannsheil Ruhr, University Bochum, Bochum, Germany.
Georgious ManousakisUniversity of Minnesota, Minneapolis, USA.
Jean Baptiste ChansonCentre de Référence des Maladies Neuromusculaires Nord/Est/Ile-de-France and ERN-EURO-NMD, Neurology Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Aleksandra Nadaj-PaklezaCentre de Référence des Maladies Neuromusculaires Nord/Est/Ile-de-France and ERN-EURO-NMD, Neurology Department, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.
Hakan CetinNeurology Department, Medical University of Vienna, Vienna, Austria.
Umesh BadrisingLeiden University Medical Center, Leiden, The Netherlands.
Jodi Warman-ChardonDepartment of Medicine (Neurology), The Ottawa Hospital, Ottawa, Canada.
Jorge BevilacquaDepartamento de Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago de Chile, Chile.
Nicholas EarleDepartamento de Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago de Chile, Chile.
Mario CamperoDepartamento de Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago de Chile, Chile.
Jorge DíazDepartamento de Neurología y Neurocirugía, Hospital Clínico Universidad de Chile, Santiago de Chile, Chile.
Chiseko IkenagaDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA.
Thomas E LloydDepartment of Neurology, Johns Hopkins University School of Medicine, Baltimore, USA.
Ichizo NishinoDepartment of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology, Tokyo, Japan.
Yukako NishimoriDepartment of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology, Tokyo, Japan.
Yoshihiko SaitoDepartment of Neuromuscular Research, National Institute of Neuroscience, National Center of Neurology, Tokyo, Japan.
Yasushi OyaDepartment of Neurology, National Center Hospital, NCNP, Tokyo, Japan.
Yoshiaki TakahashiDepartment of Neurology, Kagawa Prefectural Central Hospital, Kagawa, Japan.
Atsuko NishikawaDepartment of Neurology, Kinki Central Hospital, Hyogo, Japan.
Ryo SasakiDepartment of Neurology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan.
Chiara Marini-BettoloJohn Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute and Newcastle Hospitals NHS Foundation Trust, Center for Life, Central Parkway, Newcastle Upon Tyne, NE13BZ, United Kingdom.
Michela GuglieriJohn Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute and Newcastle Hospitals NHS Foundation Trust, Center for Life, Central Parkway, Newcastle Upon Tyne, NE13BZ, United Kingdom.
Volker StraubJohn Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute and Newcastle Hospitals NHS Foundation Trust, Center for Life, Central Parkway, Newcastle Upon Tyne, NE13BZ, United Kingdom.
Tanya StojkovicAPHP, Centre de Référence des Maladies Neuromusculaires, Institut de Myologie, Centre de Recherche en Myologie, Sorbonne Université, APHP, Hôpital Pitié-Salpêtrière, Paris, France.
Robert Y Carlier *Department of Radiology, Assistance Publique-Hôpitaux de Paris (AP-HP), DMU Start Imaging, Raymond Poincaré Teaching Hospital, Garches, France.
Jordi Díaz-Manera *John Walton Muscular Dystrophy Research Centre, Newcastle University Translational and Clinical Research Institute and Newcastle Hospitals NHS Foundation Trust, Center for Life, Central Parkway, Newcastle Upon Tyne, NE13BZ, United Kingdom. Jordi.diaz-manera@newcastle.ac.uk.ORCID http://orcid.org/0000-0003-2941-7988
Centre for Life · GBBiomedical Research Networking Center on Neurodegenerative Diseases · ESHospital Clínico de la Universidad de Chile · CLAntwerp University Hospital · BEAssistance Publique – Hôpitaux de Paris · FREginition Hospital · GRInserm · FRInstituto de Salud Carlos III · ESNational Center of Neurology and Psychiatry · JPFriedrich Baur Stiftung · DEHôpitaux Universitaires de Strasbourg · FRJohns Hopkins University · USMedical University of Warsaw · PLSorbonne Université · FRTampere University Hospital · FIUniversitat de València · ESAgostino Gemelli University Polyclinic · ITAzienda Ospedaliera Universitaria Policlinico "G. Martino" · ITBG University Hospital Bergmannsheil Bochum · DEFudan University · CN

Funding

Academy of Medical Sciences Professorship Scheme APR4/1007Medical Research Council MR/W019086/1
6 · The paper itself

Abstract

backgroundThe diagnosis of patients with mutations in the VCP gene can be complicated due to their broad phenotypic spectrum including myopathy, motor neuron disease and peripheral neuropathy. Muscle MRI guides the diagnosis in neuromuscular diseases (NMDs); however, comprehensive muscle MRI features for VCP patients have not been reported so far.

methodsWe collected muscle MRIs of 80 of the 255 patients who participated in the "VCP International Study" and reviewed the T1-weighted (T1w) and short tau inversion recovery (STIR) sequences. We identified a series of potential diagnostic MRI based characteristics useful for the diagnosis of VCP disease and validated them in 1089 MRIs from patients with other genetically confirmed NMDs.

resultsFat replacement of at least one muscle was identified in all symptomatic patients. The most common finding was the existence of patchy areas of fat replacement. Although there was a wide variability of muscles affected, we observed a common pattern characterized by the involvement of periscapular, paraspinal, gluteal and quadriceps muscles. STIR signal was enhanced in 67% of the patients, either in the muscle itself or in the surrounding fascia. We identified 10 diagnostic characteristics based on the pattern identified that allowed us to distinguish VCP disease from other neuromuscular diseases with high accuracy.

conclusionsPatients with mutations in the VCP gene had common features on muscle MRI that are helpful for diagnosis purposes, including the presence of patchy fat replacement and a prominent involvement of the periscapular, paraspinal, abdominal and thigh muscles.

Indexed as

Muscle, SkeletalMuscular DiseasesHumansMagnetic Resonance ImagingMutationValosin Containing ProteinValosin Containing ProteinVCP protein, humanMultisystemic proteinopathyMuscle MRIValosinVCP myopathy

Identifiers

PMID37603075
PMCPMC10632218
OpenAlexW4386019396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.